MediXall Group, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was USD 0 compared to USD 2,685 a year ago. Net loss was USD 5.932 million compared to USD 3.420 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.05 a year ago.